OPEN END TURBO OPTIONSSCHEIN - INMODE Stock

Certificat

DE000JQ3S9L6

Market Closed - Börse Stuttgart 06:31:58 2024-06-06 am EDT
0.65 EUR +4.84% Intraday chart for OPEN END TURBO OPTIONSSCHEIN - INMODE
Current month-4.41%
1 month+14.04%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-06 0.65 +4.84%
24-06-05 0.62 -10.14%
24-06-04 0.69 0.00%
24-06-03 0.69 +1.47%
24-05-31 0.68 +3.03%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 06:31 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying INMODE LTD.
Issuer J.P. Morgan
WKN JQ3S9L
ISINDE000JQ3S9L6
Date issued 2022-07-22
Strike 12.03 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.21
Lowest since issue 0.52

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.37 USD
Average target price
25.6 USD
Spread / Average Target
+39.36%
Consensus